Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel ( CAP-1002 ), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX⢠exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most. The Director of Biostatistics will lead statistical strategy and execution across clinical development programs, ensuring robust study design, analysis, and interpretation to support regulatory submissions and business objectives. This role provides expert guidance on statistical methodologies, oversees internal and outsourced biostatistical activities, and partners cross-functionally to deliver high-quality, compliant analyses. The Director will represent Biostatistics in regulatory interactions, contribute to clinical protocols and analysis plans, and drive innovation in statistical standards and processes. This position requires strong leadership, technical expertise, and the ability to manage complex projects in a fast-paced environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
101-250 employees